Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 315.00
Bid: 300.00
Ask: 330.00
Change: 0.00 (0.00%)
Spread: 30.00 (10.00%)
Open: 315.00
High: 315.00
Low: 315.00
Prev. Close: 315.00
CRPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

30 Apr 2024 07:00

RNS Number : 4766M
Cropper(James) PLC
30 April 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE UK'S MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, SUCH INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

30 April 2024

 

James Cropper plc

('James Cropper', the 'Company' or the 'Group')

Full Year Trading Update

FY2024 profitability expected to be slightly ahead of expectations

 

James Cropper PLC (AIM: CRPR), the Advanced Materials and Paper & Packaging group, is pleased to issue an unaudited trading update for the 52 week period to 30 March 2024 ("FY2024").

 

For FY2024, the Board expects, subject to audit, to report revenue in line with, and profits slightly ahead of its previous expectations. The outlook for FY2025 is encouraging, with a return to growth expected across both the Advanced Materials and Paper & Packaging businesses for the full year.

 

Advanced Materials

The Advanced Materials business saw a year-on-year contraction in revenue, primarily reflecting the slowdown in fuel cell market demand. This was partially offset by growth in the hydrogen electrolyser business where, despite the delays to expected projects reported in January 2024, the business continued to acquire new customers through trials and specification development with electrolyser OEMs. Targeted capital investment has continued in the business to support customers, enhance efficiency, and ensure the Advanced Materials business remains well positioned to meet the expected future growth in this area.

The core (non-hydrogen) Advanced Materials business was underpinned by growth in the aerospace and automotive sectors. The focus remains on delivering growth in these sectors, as well as carbon capture, batteries and other renewables, and defence.

The mid-term outlook for both the hydrogen and the core business remains strong.

In addition, the Board is pleased to announce the appointment of a new managing director for the Advanced Materials business, who will join the Group at the end of July 2024 and be based at the Group's main site in Burneside. The new managing director comes with over 30 years of experience in the Advanced Materials industry. An announcement containing further details will be made following notice period restrictions.

 

Paper & Packaging

Within the Paper & Packaging business, supply chain destocking compounded by the impact of high inflation on consumer confidence continued to be felt through the second half of the year.

Despite volume pressures, customer retention remained high as the business benefits from strong relationships at the channel, converter and end customer levels. Lower input costs (energy and carbon tax), mix improvements and productivity initiatives, as well as maintenance of strong average selling prices, are helping to protect margins.

Planned restructuring activity was completed during the third quarter of FY2024 on schedule, and work is ongoing to optimise the new operating model.

The future project pipeline is encouraging and forward indicators, such as order intake, point to early signs of market recovery throughout FY2025.

 

Notice of results

The Group's audited results for FY2024 are expected to be announced in July 2024.

 

Finance and net debt

The Group has managed its working capital and capital expenditure robustly, both of which are lower than the previous year, resulting in a better net debt position at the period end than previously expected.

The Group has continued to operate in compliance with its banking covenants throughout FY2024. Following the challenging trading conditions reported in the second half of FY2024, it is currently seeking temporary covenant adjustments on its UK banking facility to ensure sufficient headroom is retained. Discussions with banks have commenced and a further update will be provided in due course.

 

Steve Adams, CEO of James Cropper, said:

"I am pleased with the response from our whole organisation to the challenging trading environment over the second half of the year.

"Our priority has been a relentless focus on business development, leveraging our strong product and technology offer. We have addressed the drop in volumes by protecting our pricing, delivering continuous improvement in all our operations, driving down input costs and maintaining tight cost control.

"The Advanced Materials business has continued to strengthen its technological leadership whilst maintaining strong customer relationships, as well as building world class partnerships and identifying future accelerated growth opportunities.

"The Paper & Packaging business continues its focus on driving value growth through operational effectiveness and building on its strong brand and capability leadership in luxury packaging.

"As a Group, we have remained steadfast in focusing on our strategy for accelerated growth and the Board is confident that the growth prospects of the Group, as a whole, remain significant in the coming years."

 

 

Enquiries:

James Cropper plc

Andrew Goody, CFO

Stephen Adams, CEO

Tel: +44 (0)1539 818 202

 

Shore Capital - (Nominated Adviser and Broker)

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

Tel: +44 (0)207 408 4090

 

Buchanan Communications - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

 

Notes for editors:

 

James Cropper is a market leader in Advanced Materials and Paper Products, centred around four market audiences: Future Energy, Technical Fibres, Luxury Packaging and Creative Papers.

 

A purpose-led business, built upon six generations of the Cropper family, James Cropper has a 500+ international workforce and an operational reach in over 50 countries.

 

Established in 1845, the Group manufactures creative papers, luxury packaging and advanced materials incorporating pioneering non-wovens and electrochemical coatings.

 

James Cropper is a specialist provider of niche solutions tailored to a unique customer specification, ranging from substrates and components in hydrogen electrolysis and fuel cells to bespoke colours and textures in paper and moulded fibre packaging designed to replace single use plastics.

 

The Group operates across multiple markets from luxury retail to renewable energy. It is renowned globally for service, capability, pioneering and multi award-winning commitment to the highest standards of sustainability.

 

James Cropper's goal is to be operationally net zero by 2030 and to reduce carbon through its entire supply chain to net zero by 2050.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEFFMUELSEEL
Date   Source Headline
19th Nov 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
17th Sep 201911:20 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirectors' Dealings
9th Aug 20197:00 amRNSNotification of Transaction of PDMR
8th Aug 20197:00 amRNSDirectors' Dealings
5th Aug 20197:00 amRNSDirector/PDMR Shareholding
2nd Aug 201912:27 pmRNSGrant of Awards under Long Term Incentive Plan
1st Aug 20199:30 amRNSResult of AGM
31st Jul 201911:00 amRNSAGM Statement and Trading Update
25th Jul 20197:00 amRNSDirectorate Change
22nd Jul 201912:11 pmRNSDirector/PDMR Shareholding
22nd Jul 201910:35 amRNSReplacement - Director/PDMR Shareholding
19th Jul 20198:40 amRNSDirector/PDMR Shareholding
18th Jul 201912:40 pmRNSDirector/PDMR Shareholding
17th Jul 201910:44 amRNSDirector/PDMR Shareholding
11th Jul 20198:30 amRNSDirector/PDMR Shareholding
10th Jul 20199:15 amRNSNotice of AGM and change of website address
25th Jun 20197:00 amRNSFinal Results
20th Jun 201910:02 amRNSChange of Adviser
24th May 201910:56 amRNSDirector/PDMR Shareholding
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
22nd Mar 20197:00 amRNSDirector/PDMR Shareholding
20th Mar 20197:00 amRNSDirector/PDMR Shareholding
19th Mar 20197:00 amRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSDirector/PDMR Shareholding
1st Mar 20197:46 amRNSDirector/PDMR Shareholding
27th Feb 20197:00 amRNSDirector/PDMR Shareholding
20th Feb 20197:00 amRNSIssue of Equity
15th Feb 20197:00 amRNSDirector/PDMR Shareholding
28th Jan 201910:05 amRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSDirector/PDMR Shareholding
14th Dec 20181:59 pmRNSDirector/PDMR Shareholding
13th Dec 20187:00 amRNSIssue of Equity and Director's Dealings
6th Dec 20187:00 amRNSDirector/PDMR Shareholding
3rd Dec 201812:37 pmRNSIssue of Equity
21st Nov 20181:03 pmRNSHolding(s) in Company
21st Nov 201810:58 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSHalf-year Report
5th Oct 20182:39 pmRNSDirector/PDMR Shareholding
1st Oct 20189:39 amRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSIssue of Equity and PDMR Transactions
24th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20183:32 pmRNSDirector/PDMR Shareholding
18th Sep 20182:00 pmRNSTrading Update
11th Sep 20182:40 pmRNSDirector/PDMR Shareholding
20th Aug 20187:45 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSGrants under Long Term Incentive Plan
6th Aug 20189:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.